Peihong Zhang

机构：Northeastern University, Fujian Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Technology Holding (United States), Shanghai Institute of Nutrition and Health, First Affiliated Hospital of Fujian Medical University, Zhongshan Hospital of Xiamen University, Shanghai Sixth People's Hospital, Ministry of Science and Technology, Institute of Hematology & Blood Diseases Hospital, Children's Hospital of Fudan University, University of Chinese Academy of Sciences, Northeastern University · ORCID：0000-0003-1780-4948

发表论文 125 篇 · 总被引 1037 次 · h-index 18

代表论文

• Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer (2023 · Molecular Cancer · 被引 57)
• OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study (2023 · Journal of Thoracic Oncology · 被引 23)
• Substrate diversity of NSUN enzymes and links of 5-methylcytosine to mRNA translation and turnover (2024 · Life Science Alliance · 被引 20)
• ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms. (2023 · PubMed · 被引 10)
• Prognostic value of combined nutritional and inflammatory markers in NSCLC patients receiving ICIs (2025 · Discover Oncology · 被引 6)
• Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis (2024 · Leukemia · 被引 6)